Live-attenuated chikungunya virus vaccine.

Lisa F P Ng, Laurent Rénia

Cell 2024 Feb 15

filter terms:

all
compound
phenotype
show more »
show less «

Although Chikungunya fever does not a have a high fatality rate (<10%), it has a huge morbidity toll due to lingering chronic arthralgia. The recent FDA approval of Ixchiq, a vaccine designed to prevent infection caused by the chikungunya virus (CHIKV), provides hope that its use can prevent future CHIKV outbreaks. To view this Bench to Bedside, open or download the PDF. Copyright © 2024. Published by Elsevier Inc.